These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 20335191

  • 21. HIV and hepatitis C virus coinfection: bad bedfellows.
    Schooley RT.
    Top HIV Med; 2005; 13(4):112-6. PubMed ID: 16304454
    [Abstract] [Full Text] [Related]

  • 22. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V, Núñez M, Camino N, Maida I, Barreiro P, Romero M, Martin-Carbonero L, Garcia-Samaniego J, González-Lahoz J.
    Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
    [Abstract] [Full Text] [Related]

  • 23. Interaction between HIV-1 and HCV infections: towards a new entity?
    Winnock M, Salmon-Céron D, Dabis F, Chêne G.
    J Antimicrob Chemother; 2004 Jun; 53(6):936-46. PubMed ID: 15117928
    [Abstract] [Full Text] [Related]

  • 24. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
    Dash S, Haque S, Joshi V, Prabhu R, Hazari S, Fermin C, Garry R.
    Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514
    [Abstract] [Full Text] [Related]

  • 25. Boceprevir, an NS3 protease inhibitor of HCV.
    Berman K, Kwo PY.
    Clin Liver Dis; 2009 Aug; 13(3):429-39. PubMed ID: 19628159
    [Abstract] [Full Text] [Related]

  • 26. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K.
    Verh K Acad Geneeskd Belg; 2001 Aug; 63(5):447-73. PubMed ID: 11813503
    [Abstract] [Full Text] [Related]

  • 27. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R, Singla V, Kacharya Sk.
    Trop Gastroenterol; 2008 Aug; 29(3):136-47. PubMed ID: 19115605
    [Abstract] [Full Text] [Related]

  • 28. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management.
    Verucchi G, Calza L, Manfredi R, Chiodo F.
    Infection; 2004 Feb; 32(1):33-46. PubMed ID: 15007741
    [Abstract] [Full Text] [Related]

  • 29. [Future of antiviral therapy for chronic hepatitis C. Direct antiviral acting medications].
    Lange CM, Sarrazin C, Zeuzem S.
    Pharm Unserer Zeit; 2011 Jan; 40(1):60-7. PubMed ID: 21194084
    [No Abstract] [Full Text] [Related]

  • 30. Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals.
    Rockstroh JK.
    Liver Int; 2015 Jan; 35 Suppl 1():51-5. PubMed ID: 25529087
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. New hepatitis C regimen stimulates changes in therapy management.
    Reinke T.
    Manag Care; 2011 Dec; 20(12):41-2. PubMed ID: 22259876
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects.
    Esposito I, Labarga P, Barreiro P, Fernandez-Montero JV, de Mendoza C, Benítez-Gutiérrez L, Peña JM, Soriano V.
    Expert Opin Drug Saf; 2015 Dec; 14(9):1421-34. PubMed ID: 26212044
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Infectious diseases. First specific drugs raise hopes for hepatitis C.
    Enserink M.
    Science; 2011 Apr 08; 332(6026):159-60. PubMed ID: 21474720
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.